Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Smx Stock Faces Headwinds Key Levels In Focus 20260401 1 Wilc Stock Analysis G. Willi Food International 7.84 Drop To 24.93 Deep Dive 20260403 What Is The Long Term Potential Of Veea Veea Stock Price At 0.60 Down 6.02 20260410 Yelp Stock Analysis Yelp Inc. Holds 25.15 Post 0.16 Daily Dip In Local Services 20260403 Is Dte2077Bond Dtw Stock Showing Strength Price At 20.67 Up 0.34 20260402 Trsg Stock Analysis Tungray Technologies Inc 1.55 Pct Gain 1.31 Price Outlook 20260403 1 Is Nrx Nrxpw Stock Undervalued Now Price At 0.01 Up 62.50 20260413 Should I Buy Mplx Lp Mplx Stock In 2026 Price At 56.39 Up 0.89 20260409 Is Citius Pharma Ctxr Stock Overvalued Now Price At 0.83 Up 5.07 20260408 What Is The Valuation Of Core Sci Wts Corzz Stock Price At 18.75 Up 1.57 20260413 Is Immersion Corporation Immr Stock Stable Now Price At 5.69 Up 0.89 20260406 Should I Sell Spring Sviv Stock Now Price At 9.87 Down 0.03 20260406 Is Ceragon Crnt Stock Breaking Support Price At 2.23 Up 1.83 20260406 Is Interface Tile Stock A Buy Or Sell Price At 24.87 Down 2.20 20260406 Is Greenland Gtec Stock Testing Resistance Price At 0.75 Up 0.03 20260406 How Expensive Is Nl Industries Nl Stock Now Price At 5.78 Up 2.85 20260408 Is Trinity Trini Stock In Consolidation Phase Price At 25.10 Up 0.02 20260407 Republic Services RSG Stock Credit Default Smart Money Outflows 20260416 Is Teledyne TDY stock suitable for investment strategies 001 20260418 IPGP IPG Photonics Corporation delivers strong Q4 2025 earnings beat shares dip 267 percent amid modest revenue growth Is First FA stock a good opportunity today Investors Pile In 20260418 abrdn THW Stock Breaks Through Slight Gain 20260418 abrdn THQ Stock Price to Cash Flow In Focus 20260415 PVLA Palvella Therapeutics Inc posts wider than expected Q4 2025 loss shares dip 069 in todays trading CONMED CNMD Stock DCF Valuation 309 20260418 Getty GTY Stock Buy or Sell Q4 2025 Better Than Expected RCKTW Rocket outlines nextphase gene therapy trial expansion plans in its newly released quarterly earnings report Sequans SQNS Stock Is It a Good Opportunity Q4 2025 Below Expectations IQV IQVIA Holdings records 59 Q4 2025 yearoveryear revenue growth ticks higher despite a narrow consensus EPS miss Playtika Holding PLTK Stock Buy Decision Breakdown Playtika Holding posts 694 negative EPS surprise Market Recap Tech leads all sectors as consumer stocks lag amid mild market slips FA First Q4 2025 earnings outperform consensus estimates 83 percent year over year revenue gain lifts shares 248 percent Market Recap Tech leads sector gains as consumer names lag in mild pullback Halliburton Company HAL Q1 2026 Earnings Beat Consensus Amid Regional Operational Headwinds BRC Group RILYG Stock Is It a Good Buy Is Arm ARM stock sensitive to the economy Arm tops EPS estimates on solid AI licensing demand Illumina Inc ILMN Ford Motor Co F Defense Pivot Talks Present Underappreciated Upside Catalyst for LongTerm Investors JJSF J and J shares rise nearly 3 percent even as Q1 2026 EPS comes in below analyst estimates Are hedge funds increasing positions in Strive SATA stock SATA Latest Quarter Earnings Strive preferred reports no EPS or revenue metrics Does Orchestra OBIO have growth potential Market Focus 20260501 CIM Chimera reports Q4 2025 earnings per share above analyst projections stock registers mild daily gains Comcast Corporation CMCSA Strategic Shifts in Broadband Scale Content Distribution and Sports Access Signal Evolving Media Connectivity Strategy Vera Bradley VRA Stock Is It Changing Trend Q1 2026 Better Than Expected Coinbase Global Inc COIN Blockchaincom Launches Bespoke Blockchain Wealth Program for HighNetWorth Investors Canton CNTN Stock Chart Behavior Analysis Canton narrows loss EPS beats views by 441pct KLX Energy KLXE Stock Is It the Right Time to Invest Q4 2025 EPS Beats Forecasts What Eaton ETO revealed in previous earnings reports CAAS China Auto reports Q2 2025 earnings of 25 cents per share stock gains 136 percent NBY NovaBay Pharmaceuticals leadership outlines new clinical and commercial priorities following its latest quarterly earnings release